Pfizer halts COVID drug Paxlovid trial for standard-risk population Ruchika Sharma16 Jun 2022 9:17 AM GMTThe new data, however, showed a 51% relative risk reduction in standard-risk groups, which the company said was not statistically significant.
Pfizer-BioNTech COVID vaccines effective, safe for children aged 6 months to 4 years: USFDA staff Ruchika Sharma13 Jun 2022 8:15 AM GMTAn early analysis of data from Pfizer-BioNTech's vaccine based on 10 symptomatic COVID-19 cases identified when the Omicron coronavirus variant was...
Pfizer gets USFDA Fast Track Designation for Ervogastat plus Clesacostat to treat NASH Ruchika Sharma28 May 2022 6:27 AM GMTDiacylglycerol O-acyltransferase 2 (DGAT2) and acetyl-CoA carboxylase (ACC) are two key enzymes that regulate lipid metabolism. Inhibitors of ACC and...
Pfizer third COVID vaccine shot over 80 percent effective against Omicron in kids under 5 MD Bureau24 May 2022 10:25 AM GMTStudies in adults, adolescents, and children over 5 years of age continue to indicate that three doses of the Pfizer-BioNTech COVID-19 Vaccine...
Pfizer-BioNTech COVID booster shot gets USFDA emergency use nod for children aged 5 to 11 Ruchika Sharma18 May 2022 6:18 AM GMTThe Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech’s proprietary mRNA technology, was developed by both BioNTech and Pfizer.
Health Bulletin 17/May/2022 Isra Zaman17 May 2022 11:10 AM GMTHere are the top health stories for the day: Entry level Ayush NABH certificates given to 5 Ayurveda Hospitals Ministry of Ayush has...
USFDA to soon authorize Pfizer COVID booster shot for children aged 5 to 11: NYT Ruchika Sharma17 May 2022 5:30 AM GMTThey have cited data from a mid- to late-stage study showing a third dose of their shot increased protection against the original coronavirus version...
Generic drugmakers to sell Pfizer COVID drug Paxlovid for USD 25 or less in low-income countries Ruchika Sharma14 May 2022 5:30 AM GMTCHAI said the $25 price ceiling would apply only if there is demand from the poorer countries for at least 1 million treatment courses a year.
Evidence mounts for need to study Pfizer oral antiviral treatment Paxlovid for long COVID: Researchers Ruchika Sharma8 May 2022 5:00 AM GMTPfizer spokesman Kit Longley said company does not have any current long COVID studies underway, but was monitoring data from ongoing clinical studies...
No merit seen in including Paxlovid in Covid treatment: ICMR Roshni Dhar7 May 2022 12:09 PM GMTPfizer's antiviral drug Paxlovid is not going to be included in the national treatment guidelines for Covid-19. Confirmation to this effect was...
Health Bulletin 7/May/2022 Roshni Dhar7 May 2022 11:51 AM GMTHere are the top health stories for the day: Postpone NEETPG_Modiji: Doctors launch twitter storm While the Union Health...
Paxlovid not be included in national treatment guidelines for COVID-19, says ICMR MD Bureau7 May 2022 7:31 AM GMTExperts from the Indian Council of Medical Research (ICMR) have not found a compelling reason to include the drug in the national treatment guidelines...
